Skip to menu Skip to content Skip to footer

2025

Conference Publication

Pre-treatment impact of body composition and muscle strength on survival in women with breast cancer

Cintra Vaz Ribeiro, L., Vaz Gonçalves, L., Ribeiro Soares, L., Freitas Júnior, R., Anusca Martins, K., Gonzalez, M.C., Prado, C.M., Mota, J.F. and Marques Godinho Mota, J.C. (2025). Pre-treatment impact of body composition and muscle strength on survival in women with breast cancer. 47th ESPEN Congress, Prague, Czechia, 13-16 September 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.clnesp.2025.07.034

Pre-treatment impact of body composition and muscle strength on survival in women with breast cancer

2025

Conference Publication

Abstract P5-11-22: Neoadjuvant chemotherapy and survival outcomes in triple-negative breast cancer: a population-based study (Queensland, Australia)

Vaz-Goncalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda, Saunus, Jodi, Moore, Julie, Morris, Michelle and Reeves, Marina (2025). Abstract P5-11-22: Neoadjuvant chemotherapy and survival outcomes in triple-negative breast cancer: a population-based study (Queensland, Australia). San Antonio Breast Cancer Symposium 2024, San Antonio, TX, United States, 10-13 December 2024. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1557-3265.sabcs24-p5-11-22

Abstract P5-11-22: Neoadjuvant chemotherapy and survival outcomes in triple-negative breast cancer: a population-based study (Queensland, Australia)

2024

Conference Publication

Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort

Vaz-Goncalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda M., Saunus, Jodi M., Moore, Julie, Morris, Michelle J. and Reeves, Marina M. (2024). Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

Receipt and response to neoadjuvant chemotherapy treatment and survival outcomes in triple-negative breast cancer in Queensland: a retrospective population-based cohort

2024

Conference Publication

Investigating survival by breast cancer molecular subtype in Australia: A population-based study

Vaz-Goncalves, L., Marquart-Wilson, L., Protani, M., Stephensen, M., Saunus, J., Moore, J., Morris, M. and Reeves, M. (2024). Investigating survival by breast cancer molecular subtype in Australia: A population-based study. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.237

Investigating survival by breast cancer molecular subtype in Australia: A population-based study